Time to move beyond FIB‐4 first for MASLD screening in Type 2 diabetes.
| Autor: | Selvarajah, Janakan1 (AUTHOR), Raj, Ashok S.1 (AUTHOR) ashok.raj2@mh.org.au |
|---|---|
| Zdroj: | Liver International. Sep2024, p1. 1p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|
| Autor: | Selvarajah, Janakan1 (AUTHOR), Raj, Ashok S.1 (AUTHOR) ashok.raj2@mh.org.au |
|---|---|
| Zdroj: | Liver International. Sep2024, p1. 1p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|
Plný text